http://chineseinput.net/에서 pinyin(병음)방식으로 중국어를 변환할 수 있습니다.
변환된 중국어를 복사하여 사용하시면 됩니다.
횡격막탈장(橫隔膜脫臟) 및 횡격막이완증(橫隔膜弛緩症) -10례(例) 보고-
최수승,이정호,유영선,유회성,Choi, S.S.,Lee, J.H.,Yoo, Y.S.,Yu, H.S. 대한흉부심장혈관외과학회 1976 Journal of Chest Surgery (J Chest Surg) Vol.9 No.2
This case report included 4 cases of traumatic diaphragmatic hernias, 3 cases of non-traumatic diaphragmatic hernias, and 3 cases of eventration of the diaphragm. Among the traumatic hernias, one case was in immediate phase of traumatic diaphragmatic rupture by traffic accident, 2 cases were in intermediate phase with chronic respiratory or vague gastrointestinal symptoms after traffic accident, and the other was developed after an operation, decortication for a chronic empyema with severe pleural calcifications, damaging the diaphragm. Three cases of nontraumatic diaphragmatic hernia were presented, including 2 cases of probable Bochadlek's hernia (Parents refused operation) and a case of Morgagni's hernia with severe gastrointestinal symptoms. And three cases of eventration of the diaphragm with symptoms were also reported. Results of all treated cases were excellent.
영아에 발생(發生)한 거대(巨大) 기낭성폐기종(氣囊性肺氣腫) 2례(例) 보고(報告)
김주이,최수승,이정호,유영선,유회성,박문향,박효숙,Kim, J.E.,Choi, S.S.,Lee, J.H.,Yoo, Y.S.,Yu, H.S.,Park, M.H.,Park, H.S. 대한흉부심장혈관외과학회 1976 Journal of Chest Surgery (J Chest Surg) Vol.9 No.1
Bullous emphysema is usually associated with extensive chronic obliterative pulmonary disease. It is the disease of old age but rare in children or infancy. The bulla in this disease is acquired one. In general the symptoms are due to not the mere presence of the bulla but the extent of underlying lung pathology as emphysema or bronchitis. Occassionally giant bulla of great size may cause symptoms and in this occassion it should be differentiated from other diseases. Especially in children or infancy pneumothorax, congenital pulmonary cyst of lobar obstructive-emphysema should be excluded. Recently we experienced 2 cases of bullous emphysema in infancy with severe respiratory symptoms because of bullae of great size. We felt difficulties in differentiating with other conditions. The purpose of this report is to review our cases thoroughly and enhance considerations of this disease.
Endobronchal Hamartoma 치험(治驗) 1례(例)
김대형,최수승,이정호,유영선,유회성,박효숙,Kim, D.Y.,Choi, S.S.,Lee, J.H.,Yoo, Y.S.,Yoo, H.S.,Park, H.S. 대한흉부심장혈관외과학회 1976 Journal of Chest Surgery (J Chest Surg) Vol.9 No.1
In 1904, Albrecht first used the term "hamartoma" to refer to a congenital abnormal mixing of the normal components of an organ and is applied also to tumors found in many organs other than the lung. Though the term "hamartoma" of the lung have been used with the connection to the presence of cartilage, tumors that do not contain cartilagenous compont is also considered hamartoma. The authors experienced one case of endobronchial hamartoma. The patient, a 42-year-old woman, a teacher in a primary school, was admitted to our hospital with frequent attacks of hemoptysis. Bronchogram on the left disclosed abrupt blocking of bronchial filling at the bifurcation between postero-basal and lateral basal segmental bronchial substantiating a mass in the bronchial lumen. Left lower lobectomy was performed. The answer of pathology was benign endobronchial hamartoma. Postoperative course was uneventful. Discharged on 19th postoperative day.
항생제(抗生劑) 충전(充塡)에 의(依)한 농흉(膿胸)의 치료(治療) -Clagett 씨(氏) 방식(方式)의 원용(援用) <4예보고>-
강정호,최수승,이정호,유영선,유회성,Kang, J.H.,Choi, S.S.,Lee, J.H.,Yoo, Y.S.,Yoo, H.S. 대한흉부심장혈관외과학회 1976 Journal of Chest Surgery (J Chest Surg) Vol.9 No.1
The management of infection occurring in the space which remains after removal of lung presents considerable difficulties both for the patient and the surgeon. We have during the past one year, developed a procedure, which has been successfully applied in 4 cases of postpneumonectomy empyema by modification of Clagett's procedure. All their underlying lung diseases were pulmonary tuberculosis. The diagnosis of postpneumonectomy empyema was confirmed by thoracentesis, and bacteriologic cultures were obtained in all patients. Dead space thoracis was irrigated with various kind of antiseptic Solutions and debrided, filled with antibiotics saline solutions. The patients had a smooth post operative course except one case and was discharged from the hospital on the 3 weeks post-operative day in average. The failure case was wound leaking & redeveloped empyema, & waiting for reoperation.
말초 폐색성 동맥질환에서 Prosraglandin E1의 동맥내 투여와 정맥내 투여에 따른 효과의 비교
조범구,최수승,강면식,김해균,유경종 대한혈관외과학회 1989 Vascular Specialist International Vol.5 No.1
Twelve patients with peripheral occlusive vascular disease who were not candidates for a surgical correction or had recurrence of symptoms following previous surgical procedures were given Prostaglandin El (PGE1) to assess its effect on their subjective Group I (6 patients) received PGE1 intraarterially (0.1 0.26ng/kg/min) and group II, the same intravenously (7. 8 10 ng/kg/min), The study periods lasted 2 to 4 weeks. 1. In both groups, the skin temperature rose not only on the affected limb but also on the contralateral limb, indicating an improved skin circulation in both extremities. 2. Subjective symptom improvement were as follows ' cold sensation and numbness 100.0 % in both groups ' intermittent claudication 67.0% in group I and 33.0 % in group II; resting pain 100.0% in group I and 75.0% in group II, suggesting a slightly more favorable response in group I . 3. Objectively, the improvement in the ulcerative and necrotic changes were noted in 57.09% in group I and 71.0% in group II, showing slightly better response in group II. 4. Minor side effects such as knee joint swelling and redness at the site of catheter insertion were seen in 4 of 6 patients in group I and only 1 in group II. In summary, the intraarterial infusion of PGE1 proved to be more effective in producing improvement of subjective symptoms but associated with higher incidence of minor complications. On the other hand, the intravenous use of PGE1 appeared to be slightly more effective in the management of the ulcerative and necrotic processes. It is recommended, therefore, that a period of intravenous administration of PGE1 be tried before proceeding to the intraarterial use, if there are signs of improvement with the former method.